Alzheimer’s drug granted accelerated approval by FDA. These are the risks
CNN’s Sanjay Gupta reports the US Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug Lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
More News
Video shows officers removing tents at University of Virginia | CNN
Protesters interrupt University of Michigan commencement | CNN
Music: Adrian Sutherland’s ‘Precious Diamonds’ | CNN